1 Mohammed VI Faculty of Medicine, Mohammed VI University of Sciences and Health, Casablanca, Morocco.
2 Laboratory Medicine, Cheikh Khalifa International University Hospital, Mohammed VI University of Sciences and Health, Casablanca, Morocco.
3 Department of Pediatrics, Cheikh Khalifa International University Hospital, Mohammed VI University of Sciences and Health, Casablanca, Morocco.
World Journal of Biology Pharmacy and Health Sciences, 2026, 25(01), 266-269
Article DOI: 10.30574/wjbphs.2026.25.1.0039
Received on 14 December 2025; revised on 20 January 2026; accepted on 22 January 2026
Immune thrombocytopenic purpura (ITP) is an acquired autoimmune disorder characterized by immune-mediated platelet destruction and impaired thrombopoiesis. In infants, the occurrence of ITP requires a systematic search for secondary causes, particularly infectious etiologies. Cytomegalovirus (CMV), the most frequent cause of congenital viral infection worldwide, is known to induce profound immune dysregulation and hematopoietic abnormalities. We report the case of a three-month-old infant presenting with severe and relapsing ITP revealing a congenital CMV infection. Platelet recovery was achieved only after initiation of antiviral therapy. This case highlights the importance of an integrated immunological and biochemical diagnostic approach in infantile ITP and underscores the pathogenic role of CMV in immune-mediated thrombocytopenia.
Immune thrombocytopenia; Congenital cytomegalovirus infection; Infancy; Immune dysregulation; Megakaryopoiesis; Antiviral therapy
Get Your e Certificate of Publication using below link
Preview Article PDF
Houda Guennouni Assimi, Lina Seffar, Houda Yacoubi, Nezha Dini, and Abdelhamid Zrara. When immune thrombocytopenia purpura unveils congenital CMV infection: A case report. World Journal of Biology Pharmacy and Health Sciences, 2026, 25(01), 266-269. Article DOI: https://doi.org/10.30574/wjbphs.2026.25.1.0039